Low c-peptide is associated with high glycaemic variability and hypoglycaemia in insulin-treated patients with Type 2 diabetes

被引：0
|
作者：
Hope, S. V. [1 ,2 ]
Knight, B. A. [1 ,2 ]
Shields, B. M. [1 ,2 ]
Strain, W. D. [1 ,2 ]
Hattersley, A. T. [1 ,2 ]
Choudhary, P. [3 ]
Jones, A. G. [1 ,2 ]
机构：
[1] Univ Exeter, Exeter Natl Inst Hlth Res Clin Res Facil, Exeter, Devon, England
[2] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England
[3] Kings Coll London, Diabet Res Grp, London WC2R 2LS, England
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A39
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes
    Christensen, M. B.
    Gaede, P.
    Hommel, E.
    Gotfredsen, A.
    Norgaard, K.
    DIABETES & METABOLISM, 2020, 46 (01) : 61 - 65
  • [2] Low c-peptide is associated in insulin-treated patients with hypoglycaemia unawareness as well as hypoglycaemia frequency
    Hope, S. V.
    McDonald, T. J.
    Hill, A. V.
    Strain, W. D.
    Hattersley, A. T.
    DIABETIC MEDICINE, 2015, 32 : 158 - 158
  • [3] C-Peptide Levels Are Associated with Glycemic Variability and Hypoglycemia in Insulin-Treated Type 2 Diabetes
    Christensen, Merete B.
    Gotfredsen, Anders
    Norgaard, Kirsten
    DIABETES, 2018, 67
  • [4] Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes
    Umpierrez, Guillermo E.
    O'Neal, David
    DiGenio, Andres
    Goldenberg, Ronald
    Hernandez-Triana, Eric
    Lin, Jay
    Park, Cheol-Young
    Renard, Eric
    Kovatchev, Boris
    DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1317 - 1321
  • [5] Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
    Hope, Suzy V.
    Knight, Bridget A.
    Shields, Beverley M.
    Hill, Anita V.
    Choudhary, Pratik
    Strain, W. David
    McDonald, Timothy J.
    Jones, Angus G.
    DIABETOLOGIA, 2018, 61 (01) : 66 - 74
  • [6] Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
    Suzy V. Hope
    Bridget A. Knight
    Beverley M. Shields
    Anita V. Hill
    Pratik Choudhary
    W. David Strain
    Timothy J. McDonald
    Angus G. Jones
    Diabetologia, 2018, 61 : 66 - 74
  • [7] Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients
    Mathieu, C.
    Robbrecht, S.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 14 - 23
  • [8] C-peptide, intact proinsulin, and fasting tests in insulin-treated type 2 diabetes
    Worms, F.
    Bruns, W.
    DIABETES STOFFWECHSEL UND HERZ, 2008, 17 (02): : 85 - 93
  • [9] C-peptide concentrations in patients with type 2 diabetes treated with insulin
    Uzunlulu, Mehmet
    Oguz, Aytekin
    Bahadir, Muzeyyen Arslan
    Erbakan, Ayse Naciye
    Keskinler, Mirac Vural
    Mesci, Banu Alpaslan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (06) : 3099 - 3104
  • [10] Severe hypoglycaemia in insulin-treated Type 2 diabetes
    Geddes, J.
    Frier, B. M.
    DIABETIC MEDICINE, 2007, 24 (03) : 327 - 327
12345